Ignite Creation Date:
2024-05-06 @ 10:05 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03157128
Status:
RECRUITING
Last Update Posted:
2024-03-04
First Post:
2017-05-09
Brief Title:
A Study of Selpercatinib LOXO-292 in Participants With Advanced Solid Tumors RET Fusion-Positive Solid Tumors and Medullary Thyroid Cancer LIBRETTO-001
Sponsor:
Organization:
Eli Lilly and Company